APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prilide Antihypertensive Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Prilide Antihypertensive Drugs Industry Research Report 2026

22 December 2025139 pages

Choose your research edition.

Industry ResearchPrilide Antihypertensive Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Prilide Antihypertensive Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Prilide Antihypertensive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prilide Antihypertensive Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Prilide Antihypertensive Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Prilide Antihypertensive Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Prilide Antihypertensive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Prilide Antihypertensive Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Prilide Antihypertensive Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Prilide Antihypertensive Drugs include Zhongfu Pharmaceutical, Huahai Pharmaceutical, Changjiang Pharmaceutical, Abbott, Sanofi, Humanwell Pharmaceutical, Poly Pharm, Novartis and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Prilide Antihypertensive Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Prilide Antihypertensive Drugs Market by Company

Zhongfu Pharmaceutical

Huahai Pharmaceutical

Changjiang Pharmaceutical

Abbott

Sanofi

Humanwell Pharmaceutical

Poly Pharm

Novartis

Merck

Lukang Group

Likang Pharmaceutical

Pfizer

Hengwei Pharmaceutical

Hengcheng Pharmaceutical

Changzhou Pharmaceutical

Baili Pharmaceutical

Baiyunshan Pharmaceutical

Prilide Antihypertensive Drugs Segment by Type

Enalapril

Lisinopril

Captopril

Fosinopril

Others

Prilide Antihypertensive Drugs Segment by Application

Hospital

Clinic

Prilide Antihypertensive Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prilide Antihypertensive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prilide Antihypertensive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prilide Antihypertensive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Prilide Antihypertensive Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Prilide Antihypertensive Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Prilide Antihypertensive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Prilide Antihypertensive Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Prilide Antihypertensive Drugs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Prilide Antihypertensive Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Prilide Antihypertensive Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Prilide Antihypertensive Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Prilide Antihypertensive Drugs Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Prilide Antihypertensive Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Prilide Antihypertensive Drugs, Product Type & Application Table 14. Global Prilide Antihypertensive Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Prilide Antihypertensive Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhongfu Pharmaceutical Company Information Table 19. Zhongfu Pharmaceutical Business Overview Table 20. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 22. Zhongfu Pharmaceutical Recent Developments Table 23. Huahai Pharmaceutical Company Information Table 24. Huahai Pharmaceutical Business Overview Table 25. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 27. Huahai Pharmaceutical Recent Developments Table 28. Changjiang Pharmaceutical Company Information Table 29. Changjiang Pharmaceutical Business Overview Table 30. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 32. Changjiang Pharmaceutical Recent Developments Table 33. Abbott Company Information Table 34. Abbott Business Overview Table 35. Abbott Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Abbott Prilide Antihypertensive Drugs Product Portfolio Table 37. Abbott Recent Developments Table 38. Sanofi Company Information Table 39. Sanofi Business Overview Table 40. Sanofi Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Sanofi Prilide Antihypertensive Drugs Product Portfolio Table 42. Sanofi Recent Developments Table 43. Humanwell Pharmaceutical Company Information Table 44. Humanwell Pharmaceutical Business Overview Table 45. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 47. Humanwell Pharmaceutical Recent Developments Table 48. Poly Pharm Company Information Table 49. Poly Pharm Business Overview Table 50. Poly Pharm Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Poly Pharm Prilide Antihypertensive Drugs Product Portfolio Table 52. Poly Pharm Recent Developments Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Novartis Prilide Antihypertensive Drugs Product Portfolio Table 57. Novartis Recent Developments Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Merck Prilide Antihypertensive Drugs Product Portfolio Table 62. Merck Recent Developments Table 63. Lukang Group Company Information Table 64. Lukang Group Business Overview Table 65. Lukang Group Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Lukang Group Prilide Antihypertensive Drugs Product Portfolio Table 67. Lukang Group Recent Developments Table 68. Likang Pharmaceutical Company Information Table 69. Likang Pharmaceutical Business Overview Table 70. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Likang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 72. Likang Pharmaceutical Recent Developments Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Pfizer Prilide Antihypertensive Drugs Product Portfolio Table 77. Pfizer Recent Developments Table 78. Hengwei Pharmaceutical Company Information Table 79. Hengwei Pharmaceutical Business Overview Table 80. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 82. Hengwei Pharmaceutical Recent Developments Table 83. Hengcheng Pharmaceutical Company Information Table 84. Hengcheng Pharmaceutical Business Overview Table 85. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 87. Hengcheng Pharmaceutical Recent Developments Table 88. Changzhou Pharmaceutical Company Information Table 89. Changzhou Pharmaceutical Business Overview Table 90. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 92. Changzhou Pharmaceutical Recent Developments Table 93. Baili Pharmaceutical Company Information Table 94. Baili Pharmaceutical Business Overview Table 95. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Baili Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 97. Baili Pharmaceutical Recent Developments Table 98. Baiyunshan Pharmaceutical Company Information Table 99. Baiyunshan Pharmaceutical Business Overview Table 100. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 102. Baiyunshan Pharmaceutical Recent Developments Table 103. Global Prilide Antihypertensive Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Prilide Antihypertensive Drugs Sales by Region (2021-2026) & (k units) Table 105. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2021-2026) Table 106. Global Prilide Antihypertensive Drugs Sales by Region (2027-2032) & (k units) Table 107. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2027-2032) Table 108. Global Prilide Antihypertensive Drugs Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2021-2026) Table 110. Global Prilide Antihypertensive Drugs Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2027-2032) Table 112. North America Prilide Antihypertensive Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 114. North America Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 115. North America Prilide Antihypertensive Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Prilide Antihypertensive Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Prilide Antihypertensive Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 119. Europe Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 120. Europe Prilide Antihypertensive Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Prilide Antihypertensive Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Prilide Antihypertensive Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Prilide Antihypertensive Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Prilide Antihypertensive Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Prilide Antihypertensive Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 129. South America Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 130. South America Prilide Antihypertensive Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Prilide Antihypertensive Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Prilide Antihypertensive Drugs Sales by Type (2021-2026) & (k units) Table 138. Global Prilide Antihypertensive Drugs Sales by Type (2027-2032) & (k units) Table 139. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2026) Table 140. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2027-2032) Table 141. Global Prilide Antihypertensive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Prilide Antihypertensive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2026) Table 144. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2027-2032) Table 145. Global Prilide Antihypertensive Drugs Price by Type (2021-2026) & (US$/unit) Table 146. Global Prilide Antihypertensive Drugs Price by Type (2027-2032) & (US$/unit) Table 147. Global Prilide Antihypertensive Drugs Sales by Application (2021-2026) & (k units) Table 148. Global Prilide Antihypertensive Drugs Sales by Application (2027-2032) & (k units) Table 149. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2026) Table 150. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2027-2032) Table 151. Global Prilide Antihypertensive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Prilide Antihypertensive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2026) Table 154. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2027-2032) Table 155. Global Prilide Antihypertensive Drugs Price by Application (2021-2026) & (US$/unit) Table 156. Global Prilide Antihypertensive Drugs Price by Application (2027-2032) & (US$/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Prilide Antihypertensive Drugs Distributors List Table 160. Prilide Antihypertensive Drugs Customers List Table 161. Prilide Antihypertensive Drugs Industry Trends Table 162. Prilide Antihypertensive Drugs Industry Drivers Table 163. Prilide Antihypertensive Drugs Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Prilide Antihypertensive Drugs Product Image Figure 5. Global Prilide Antihypertensive Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Prilide Antihypertensive Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Prilide Antihypertensive Drugs Sales (2021-2032) & (k units) Figure 8. Global Prilide Antihypertensive Drugs Average Price (US$/unit) & (2021-2032) Figure 9. Enalapril Product Image Figure 10. Lisinopril Product Image Figure 11. Captopril Product Image Figure 12. Fosinopril Product Image Figure 13. Others Product Image Figure 14. Hospital Product Image Figure 15. Clinic Product Image Figure 16. Global Prilide Antihypertensive Drugs Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Prilide Antihypertensive Drugs Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Prilide Antihypertensive Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Prilide Antihypertensive Drugs Sales by Region in 2025 Figure 22. Global Prilide Antihypertensive Drugs Revenue by Region in 2025 Figure 23. North America Prilide Antihypertensive Drugs Market Size by Country in 2025 Figure 24. North America Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 25. North America Prilide Antihypertensive Drugs Revenue Market Share by Country (2021-2032) Figure 26. United States Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Prilide Antihypertensive Drugs Market Size by Country in 2025 Figure 30. Europe Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 31. Europe Prilide Antihypertensive Drugs Revenue Market Share by Country (2021-2032) Figure 32. Germany Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Prilide Antihypertensive Drugs Market Size by Country in 2025 Figure 43. Asia Pacific Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Prilide Antihypertensive Drugs Revenue Market Share by Country (2021-2032) Figure 45. China Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Prilide Antihypertensive Drugs Market Size by Country in 2025 Figure 54. South America Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 55. South America Prilide Antihypertensive Drugs Revenue Market Share by Country (2021-2032) Figure 56. Brazil Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Prilide Antihypertensive Drugs Market Size by Country in 2025 Figure 60. Middle East and Africa Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Prilide Antihypertensive Drugs Revenue Market Share by Country (2021-2032) Figure 62. Egypt Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Prilide Antihypertensive Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2032) Figure 68. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2032) Figure 69. Global Prilide Antihypertensive Drugs Price (US$/unit) by Type (2021-2032) Figure 70. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2032) Figure 71. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2032) Figure 72. Global Prilide Antihypertensive Drugs Price (US$/unit) by Application (2021-2032) Figure 73. Prilide Antihypertensive Drugs Value Chain Figure 74. Prilide Antihypertensive Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Prilide Antihypertensive Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Enalapril
  • Lisinopril
  • Captopril
  • Fosinopril
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Zhongfu Pharmaceutical
  • Huahai Pharmaceutical
  • Changjiang Pharmaceutical
  • Abbott
  • Sanofi
  • Humanwell Pharmaceutical
  • Poly Pharm
  • Novartis
  • Merck
  • Lukang Group
  • Likang Pharmaceutical
  • Pfizer
  • Hengwei Pharmaceutical
  • Hengcheng Pharmaceutical
  • Changzhou Pharmaceutical
  • Baili Pharmaceutical
  • Baiyunshan Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Prilide Antihypertensive Drugs Market Size (2021-2032)
  4. 2.2.2 Global Prilide Antihypertensive Drugs Sales (2021-2032)
  5. 2.2.3 Global Prilide Antihypertensive Drugs Market Average Price (2021-2032)
  6. 2.3 Prilide Antihypertensive Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Enalapril
  9. 2.3.3 Lisinopril
  10. 2.3.4 Captopril
  11. 2.3.5 Fosinopril
  12. 2.3.6 Others
  13. 2.4 Prilide Antihypertensive Drugs by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Hospital
  16. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Prilide Antihypertensive Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Prilide Antihypertensive Drugs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Prilide Antihypertensive Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Prilide Antihypertensive Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Prilide Antihypertensive Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Prilide Antihypertensive Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Prilide Antihypertensive Drugs, Established Date
  9. 3.9 Global Prilide Antihypertensive Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhongfu Pharmaceutical
  2. 4.1.1 Zhongfu Pharmaceutical Company Information
  3. 4.1.2 Zhongfu Pharmaceutical Business Overview
  4. 4.1.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  6. 4.1.5 Zhongfu Pharmaceutical Recent Developments
  7. 4.2 Huahai Pharmaceutical
  8. 4.2.1 Huahai Pharmaceutical Company Information
  9. 4.2.2 Huahai Pharmaceutical Business Overview
  10. 4.2.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  12. 4.2.5 Huahai Pharmaceutical Recent Developments
  13. 4.3 Changjiang Pharmaceutical
  14. 4.3.1 Changjiang Pharmaceutical Company Information
  15. 4.3.2 Changjiang Pharmaceutical Business Overview
  16. 4.3.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  18. 4.3.5 Changjiang Pharmaceutical Recent Developments
  19. 4.4 Abbott
  20. 4.4.1 Abbott Company Information
  21. 4.4.2 Abbott Business Overview
  22. 4.4.3 Abbott Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Abbott Prilide Antihypertensive Drugs Product Portfolio
  24. 4.4.5 Abbott Recent Developments
  25. 4.5 Sanofi
  26. 4.5.1 Sanofi Company Information
  27. 4.5.2 Sanofi Business Overview
  28. 4.5.3 Sanofi Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sanofi Prilide Antihypertensive Drugs Product Portfolio
  30. 4.5.5 Sanofi Recent Developments
  31. 4.6 Humanwell Pharmaceutical
  32. 4.6.1 Humanwell Pharmaceutical Company Information
  33. 4.6.2 Humanwell Pharmaceutical Business Overview
  34. 4.6.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  36. 4.6.5 Humanwell Pharmaceutical Recent Developments
  37. 4.7 Poly Pharm
  38. 4.7.1 Poly Pharm Company Information
  39. 4.7.2 Poly Pharm Business Overview
  40. 4.7.3 Poly Pharm Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Poly Pharm Prilide Antihypertensive Drugs Product Portfolio
  42. 4.7.5 Poly Pharm Recent Developments
  43. 4.8 Novartis
  44. 4.8.1 Novartis Company Information
  45. 4.8.2 Novartis Business Overview
  46. 4.8.3 Novartis Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Novartis Prilide Antihypertensive Drugs Product Portfolio
  48. 4.8.5 Novartis Recent Developments
  49. 4.9 Merck
  50. 4.9.1 Merck Company Information
  51. 4.9.2 Merck Business Overview
  52. 4.9.3 Merck Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Merck Prilide Antihypertensive Drugs Product Portfolio
  54. 4.9.5 Merck Recent Developments
  55. 4.10 Lukang Group
  56. 4.10.1 Lukang Group Company Information
  57. 4.10.2 Lukang Group Business Overview
  58. 4.10.3 Lukang Group Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Lukang Group Prilide Antihypertensive Drugs Product Portfolio
  60. 4.10.5 Lukang Group Recent Developments
  61. 4.11 Likang Pharmaceutical
  62. 4.11.1 Likang Pharmaceutical Company Information
  63. 4.11.2 Likang Pharmaceutical Business Overview
  64. 4.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Likang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  66. 4.11.5 Likang Pharmaceutical Recent Developments
  67. 4.12 Pfizer
  68. 4.12.1 Pfizer Company Information
  69. 4.12.2 Pfizer Business Overview
  70. 4.12.3 Pfizer Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Pfizer Prilide Antihypertensive Drugs Product Portfolio
  72. 4.12.5 Pfizer Recent Developments
  73. 4.13 Hengwei Pharmaceutical
  74. 4.13.1 Hengwei Pharmaceutical Company Information
  75. 4.13.2 Hengwei Pharmaceutical Business Overview
  76. 4.13.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  78. 4.13.5 Hengwei Pharmaceutical Recent Developments
  79. 4.14 Hengcheng Pharmaceutical
  80. 4.14.1 Hengcheng Pharmaceutical Company Information
  81. 4.14.2 Hengcheng Pharmaceutical Business Overview
  82. 4.14.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  84. 4.14.5 Hengcheng Pharmaceutical Recent Developments
  85. 4.15 Changzhou Pharmaceutical
  86. 4.15.1 Changzhou Pharmaceutical Company Information
  87. 4.15.2 Changzhou Pharmaceutical Business Overview
  88. 4.15.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  90. 4.15.5 Changzhou Pharmaceutical Recent Developments
  91. 4.16 Baili Pharmaceutical
  92. 4.16.1 Baili Pharmaceutical Company Information
  93. 4.16.2 Baili Pharmaceutical Business Overview
  94. 4.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Baili Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  96. 4.16.5 Baili Pharmaceutical Recent Developments
  97. 4.17 Baiyunshan Pharmaceutical
  98. 4.17.1 Baiyunshan Pharmaceutical Company Information
  99. 4.17.2 Baiyunshan Pharmaceutical Business Overview
  100. 4.17.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  102. 4.17.5 Baiyunshan Pharmaceutical Recent Developments
5 Global Prilide Antihypertensive Drugs Market Scenario by Region
  1. 5.1 Global Prilide Antihypertensive Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Prilide Antihypertensive Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Prilide Antihypertensive Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Prilide Antihypertensive Drugs Sales by Region: 2027-2032
  5. 5.3 Global Prilide Antihypertensive Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Prilide Antihypertensive Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Prilide Antihypertensive Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Prilide Antihypertensive Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Prilide Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Prilide Antihypertensive Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Prilide Antihypertensive Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Prilide Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Prilide Antihypertensive Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Prilide Antihypertensive Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Prilide Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Prilide Antihypertensive Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Prilide Antihypertensive Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Prilide Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Prilide Antihypertensive Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Prilide Antihypertensive Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Prilide Antihypertensive Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Prilide Antihypertensive Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Prilide Antihypertensive Drugs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Prilide Antihypertensive Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Prilide Antihypertensive Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Prilide Antihypertensive Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Prilide Antihypertensive Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Prilide Antihypertensive Drugs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Prilide Antihypertensive Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Prilide Antihypertensive Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Prilide Antihypertensive Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Prilide Antihypertensive Drugs Value Chain Analysis
  2. 8.1.1 Prilide Antihypertensive Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Prilide Antihypertensive Drugs Production Mode & Process
  5. 8.2 Prilide Antihypertensive Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Prilide Antihypertensive Drugs Distributors
  8. 8.2.3 Prilide Antihypertensive Drugs Customers
9 Global Prilide Antihypertensive Drugs Analyzing Market Dynamics
  1. 9.1 Prilide Antihypertensive Drugs Industry Trends
  2. 9.2 Prilide Antihypertensive Drugs Industry Drivers
  3. 9.3 Prilide Antihypertensive Drugs Industry Opportunities and Challenges
  4. 9.4 Prilide Antihypertensive Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst